Skip to main content

Military Health System

You also may be interested in...

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

DOD Privacy and Civil Liberties Programs

Policy

This DODI establishes policy, assigns responsibilities, and prescribes procedures for administering the DOD Privacy and Civil Liberties Programs.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

Reasonable Accommodations

Policy

Establishes the DHA's procedures to set procedures, responsibilities, and implement guidance for administering the DHA RA Program in accordance with federal guidelines.

  • Identification #: 1020.01
  • Date: 11/2/2020
  • Type: Administrative Instructions
  • Topics: Disability Evaluation

PGI 224.1-90: Personally Identifiable Information (PII), Protected Health Information (PHI), and Federal Information Requirements

Policy

This PGI provides standard language that shall be included in all purchased and non-purchased care solicitations and contracts where the contractor’s performance involves access to PII/PHI (unless those solicitations and contracts incorporate the TRICARE Manuals in their entirety, in which case this PGI does not apply).

CMS Checklist for MTF Claims

Policy

CMS Checklist for MTF Claims

  • Identification #: N/A
  • Date: 10/8/2020
  • Type: Guidelines
  • Topics: N/A

Military Service by Transgender Persons and Persons with Gender Dysphoria

Policy

In accordance with the authority in DOD Directive 5124.02, this issuance establishes policy, assigns responsibilities, and prescribes procedures regarding the standards for military service accession, retention, separation, in-service transition, and medical care for Service members and applicants for accession to the Military Services with gender dysphoria or who are transgender, as applicable.

DOD Pharmaceutical & Therapeutics Committee Charter

Policy

The Department of Defense (DOD) Pharmacy and Therapeutics (P&T) Committee (henceforth, P&T Committee) is responsible for development and maintenance of the TRICARE Uniform Formulary. This charter outlines the roles and responsibilities of the DOD P&T Committee.

  • Identification #: N/A
  • Date: 8/31/2020
  • Type: Guidelines
  • Topics: N/A

CY19 Outpatient Rates Letter_Revised

Policy

CY 2020 Outpatient Rates Memorandum

Policy

Guidance for the DoD Influenza Vaccination Program (IVP)

Policy

Implements instructions, assigns responsibilities, and prescribes procedures for the DOD Northern Hemisphere (NH) and Southern Hemisphere (SH) Seasonal influenza vaccination program.

MILPERSMAN 1730-020 Immunization Exemptions for Religious Beliefs

Policy

Process for requesting immunization exemptions, pursuant to the Navy Military Personnel Manual.

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

<< < 1 2 3 4 5  ... > >> 
Showing results 46 - 60 Page 4 of 70
Refine your search
Last Updated: October 18, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery